methionine sulfoximine has been researched along with Acute Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, P; Brusilow, WS; Chiara, F; Jambekar, AA; Needleman, R; Nicolosi, L; Palma, E; Petronilli, V; Rasola, A | 1 |
| Cooper, AJ | 1 |
1 review(s) available for methionine sulfoximine and Acute Hepatic Failure
| Article | Year |
|---|---|
Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase.
Topics: Ammonia; Animals; Brain; Enzyme Inhibitors; Glutamate-Ammonia Ligase; Hepatic Encephalopathy; Homeostasis; Humans; Hyperammonemia; Liver; Liver Diseases; Liver Failure, Acute; Methionine Sulfoximine | 2013 |
1 other study(ies) available for methionine sulfoximine and Acute Hepatic Failure
| Article | Year |
|---|---|
A glutamine synthetase inhibitor increases survival and decreases cytokine response in a mouse model of acute liver failure.
Topics: Animals; Apoptosis; Cells, Cultured; Cytokines; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Galactosamine; Glutamate-Ammonia Ligase; Inflammation Mediators; Interferon-gamma; Lipopolysaccharides; Liver; Liver Failure, Acute; Macrophages, Peritoneal; Male; Methionine Sulfoximine; Mice; STAT1 Transcription Factor; Time Factors; Tumor Necrosis Factor-alpha | 2011 |